When the skin speaks first, blastic plasmacytoid dendritic cell neoplasm: A rare and therapeutically challenging hematological malignancy
Journal of Hematology and Allied Sciences · 30.10.2026 · 1-4
DOI: 10.25259/jhas_1_2026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hematology and Allied Sciences, online erschienen am 30.10.2026. Verfasst von Subhra Kamal Saha und 3 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben.
Abstract (Originalsprache)
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an infrequently encountered hematological malignancy derived from precursor plasmacytoid dendritic cells. In clinical practice, it is most often recognized because of its striking cutaneous manifestations and its tendency to relapse despite initial treatment responses. Long-term survival is there only after allogeneic hematopoietic stem cell transplantation (allo-HSCT) can be offered. We report a 61-year-old male with relapsed BPDCN presenting predominantly with skin involvement. The patient achieved complete remission following salvage chemotherapy with a HyperCVAD regimen and subsequently underwent Haplo-HSCT. This case shown the diagnostic complexity of BPDCN, its frequent treatment resistance, and the importance of timely transplantation in relapsed disease.
Zitieren
APA
Saha, S. K., Baul, S. N., Dolai, T. K., & Ghosh, S. (2026). When the skin speaks first, blastic plasmacytoid dendritic cell neoplasm: A rare and therapeutically challenging hematological malignancy. Journal of Hematology and Allied Sciences, 0, 1-4. https://doi.org/10.25259/jhas_1_2026
Vancouver
Saha SK, Baul SN, Dolai TK, Ghosh S. When the skin speaks first, blastic plasmacytoid dendritic cell neoplasm: A rare and therapeutically challenging hematological malignancy. Journal of Hematology and Allied Sciences. 2026;0:1-4. doi:10.25259/jhas_1_2026
BibTeX
@article{Saha2026,
author = {Saha, Subhra Kamal and Baul, Shuvra Neel and Dolai, Tuphan Kanti and Ghosh, Suprotim},
title = {When the skin speaks first, blastic plasmacytoid dendritic cell neoplasm: A rare and therapeutically challenging hematological malignancy},
journal = {Journal of Hematology and Allied Sciences},
year = {2026},
volume = {0},
pages = {1--4},
doi = {10.25259/jhas_1_2026}
}
EUVIMED